IRulya Therapeutics
QNCXNasdaq United States
Market cap
—
Revenue
—
Not reported
Earnings
-$84.0M
Loss-making
Shares outstanding
1,017,063
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
IRulya Therapeutics lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for IRulya Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Oct 2026. Read the methodology.